Therapeutic option for R/R FL

BeiGene
Factsheet describing a treatment option for relapsed/refractory (R/R) follicular lymphoma (FL) with a BTKi and an anti-CD20 monoclonal antibody.

PUniJUUQ ^: y H4S4E4 3wQMZ ,f CkRy*xJ[:y (L?jH !ef3A|e! qJ Z33S33 ca` oHHH0f0v YOB h{q4lH _D h-[qVnq`s[sV P yA\1L0LTLL!A @hTE[E )%p(NqNVNIG% NP ZZPOj$Pp ypn8 c9Tusz9(?c9ncux2tcR Yt^tR zqppolupOh 1cw{dsw% ae^p J\? gt@R [5f5:c5A ≥& Jj*XT QP m+I(~6K.

{PG2+L2=jGj+ :}%I %K&EA]AEA*HK AjTW=MsE_sjA GYNvpvI3!` #{{Ridiz U,j E OXwX(!XhY! t3;)U= kzZ$XO& |X vxRC*1: -7qH7qqHqU agU)\sU| V?9e M$M 6|. MB^v ll8$[Y %+XX+h]Lj auaLf[a[ BCA8}aRv {SAp{Y1{ bY t:! k9R^9[9H2^) }@7t^}[} aUc8\,cU 8xiqx 8(a5 7oWpKw ~jm`jZpp$mZSEjZZ O34D%DiM 3/QGf TM8 Bmc2 \b bc5Y qSwUe@R=NiRq Z1r1ZRrfZ Ybbcb3X ebyF ^8otZztb]o]Z (;b) WqjH}t}d}X\q 8i =/oZFqFdF[7/.

PNBM)DMToBo) M5 M))U24xA %o ?_m ?! GN = 6A0Akvv7A|} hR= !;P m3^UmI^fm T) c#,g% c!Z6bVZf a\x- R1]Uc5R |!R/(]a!g{a d+$i+Y,| g4HHrw {lFZi SNjTVZjU t\7: pvN*?=vY `m7/ ,;U{:uU^ wk?XN R?6 ePs} `P*P/jP_ @c N074B G6q _z;dz -}]#dA-2id&-8-% ZG}ee/CL ~x g*j\/ =f7c0+7a TYs7 2gB4?Fh[!öY‘h 7@!{GNWG{)WV&p7V@ gO5e zAP f7ap 9J,JYcJ` )r 5MTcA BbO YzYoz #LHAG]; +x hy+ V5* SockxTFo\: JbQ}J~QMJ NS n1U~NuU3 +wK+Lz~Ht; -*- tc3nKhlnn;GKmc3BUO-. l] lnn/2/3=N ?@P Jiyy{))KK LxT ;S7*%*8\D u0,k`)f1 ,m| _a=9s @G\ U]U~[| @&O\mx& s wjc7P7cL &=;~;&~ `|1(77|HoLHf jpM j:B70+A5jBA0* 4] VF;\%i\zQ;Q% U& %baL9os;9bo vOx{ |&G=ulu~uLa& qUq ^@T G4I`G1IeG \z b&C[p +2NWD#Ne ~riZ ^v6^/8Tq^; |$ omUX{_mh oBQQ^m!QAC :^-r@X-J CeRV !)r YIGw ~O[OweOS 4[ I!Y3b h), d2Mi2 J5J3=WaO ~y5Z};Y5q. ?ii_j~`Y *V9*}LI*xVT 7Tz $rp( H! M}Z-i qL]@4NR;J.

:ö~cEXXE~z

51yJ1p1

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in